Clinical Trial Update: Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy [Phase 2]

View source ↗

Summary

This Phase IIb multicenter randomized controlled trial is evaluating the efficacy of Sivelestat in patients with septic coagulopathy and is currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulopathy
• Septic Shock

Drugs mentioned

• Sivelestat (sivelestat)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Septic Shock, Coagulopathy | Phase 2 | Status: NOT_YET_RECRUITING